Drug Profile
Dapoxetine - Yuhan Corporation
Alternative Names: IMD dapoxetine; YHD 1044Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Yuhan
- Class Antidepressants; Benzylamines; Naphthalenes; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Premature ejaculation
Most Recent Events
- 26 Nov 2018 Discontinued - Phase-III for Premature ejaculation in South Korea (PO)
- 23 Sep 2015 No recent reports on development identified - Phase-III for Premature ejaculation in South Korea (PO)
- 31 May 2012 Yuhan Corporation completes a phase I/IIa trial in Premature ejaculation in South Korea (NCT01419470)